Topiramate

Product NDC
33261-106
11-digit product format
332610106
Labeler code
33261
Product ID
33261-106_e1c475c2-3437-4249-af16-1f9142ff1941
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Topiramate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Aidarex Pharmaceuticals LLC
Application
ANDA077627
Marketing category
ANDA
Marketing start
2009-03-27
Marketing end
0000-00-00
Substance
TOPIRAMATE
Active strength
25 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e5b1b0ba-27f8-4d5d-8943-8aed080fdedcProduct name420260306
6c26dd6d-01b5-4a80-b096-b3a6f7ca6077Product name220250623
cb966f54-bbf0-40fb-b581-80c6648d510cProduct name420250623
6e2fb0d7-40d7-e97c-1375-fa022ff20193Product name420250305
3d272a3f-17c0-421d-bc43-3cbdb719258dProduct name120250303

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
33261-106-072020-01-31C16284748780-19d75b9d0-763f-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Topiramate Tablets safely and effectively. See full prescribing information for Topiramate Tablets. TOPIRAMATE TABLETS USP for oral use Initial U.S. Approval: 1996
33261-106-142020-01-31C16284748780-19d75b9d0-763f-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Topiramate Tablets safely and effectively. See full prescribing information for Topiramate Tablets. TOPIRAMATE TABLETS USP for oral use Initial U.S. Approval: 1996
33261-106-282020-01-31C16284748780-19d75b9d0-763f-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Topiramate Tablets safely and effectively. See full prescribing information for Topiramate Tablets. TOPIRAMATE TABLETS USP for oral use Initial U.S. Approval: 1996
33261-106-302020-01-31C16284748780-19d75b9d0-763f-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Topiramate Tablets safely and effectively. See full prescribing information for Topiramate Tablets. TOPIRAMATE TABLETS USP for oral use Initial U.S. Approval: 1996
33261-106-452020-01-31C16284748780-19d75b9d0-763f-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Topiramate Tablets safely and effectively. See full prescribing information for Topiramate Tablets. TOPIRAMATE TABLETS USP for oral use Initial U.S. Approval: 1996
33261-106-602020-01-31C16284748780-19d75b9d0-763f-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Topiramate Tablets safely and effectively. See full prescribing information for Topiramate Tablets. TOPIRAMATE TABLETS USP for oral use Initial U.S. Approval: 1996
33261-106-902020-01-31C16284748780-19d75b9d0-763f-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Topiramate Tablets safely and effectively. See full prescribing information for Topiramate Tablets. TOPIRAMATE TABLETS USP for oral use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
33261-106-07Topiramate7 in 1 BOTTLE, PLASTICTABLET, FILM COATED71
33261-106-14Topiramate14 in 1 BOTTLE, PLASTICTABLET, FILM COATED141
33261-106-28Topiramate28 in 1 BOTTLE, PLASTICTABLET, FILM COATED281
33261-106-30Topiramate30 in 1 BOTTLE, PLASTICTABLET, FILM COATED301
33261-106-45Topiramate45 in 1 BOTTLE, PLASTICTABLET, FILM COATED451
33261-106-60Topiramate60 in 1 BOTTLE, PLASTICTABLET, FILM COATED601
33261-106-90Topiramate90 in 1 BOTTLE, PLASTICTABLET, FILM COATED901

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
33261-106-07EA - Each33261-106dd042328-87ed-4ed8-b00c-69f471ebb78512015-10-02
33261-106-14EA - Each33261-1069288410d-a410-4f24-afd6-eaf817906e4412015-10-02
33261-106-28EA - Each33261-106706e2e5d-ebb9-4d37-9326-0b523423e77812015-10-02
33261-106-30EA - Each33261-106510060dd-96e0-41ae-a393-3bbb882505aa12015-10-02
33261-106-45EA - Each33261-1063e95bee7-eef5-4e50-8fbc-aabd1acfed9212015-10-02
33261-106-60EA - Each33261-106220c8352-e59f-49a9-86aa-63977ccd3f9712015-10-02
33261-106-90EA - Each33261-106a4a1ff07-dea2-497b-a6e9-8b65870edef212015-10-02

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
33261-106TOPIRAMATE TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC]1Legacy NDC, 7 package rows20140213_89109cf7-404a-4949-9ef8-a1e749b37de4.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
199888topiramate 25 MG Oral TabletPSN89109cf7-404a-4949-9ef8-a1e749b37de41
199888topiramate 25 MG Oral TabletSCD89109cf7-404a-4949-9ef8-a1e749b37de41

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
33261-106-07332610106077 in 1 BOTTLE, PLASTICHistorical
33261-106-143326101061414 in 1 BOTTLE, PLASTICHistorical
33261-106-283326101062828 in 1 BOTTLE, PLASTICHistorical
33261-106-303326101063030 in 1 BOTTLE, PLASTICHistorical
33261-106-453326101064545 in 1 BOTTLE, PLASTICHistorical
33261-106-603326101066060 in 1 BOTTLE, PLASTICHistorical
33261-106-903326101069090 in 1 BOTTLE, PLASTICHistorical